Evidence map›Paper›PMID 41734200›Full record

ArticlePloS one2026

Antibiotic stewardship benchmarking-Using the WHO point prevalence survey of antimicrobial prescribing in a Tertiary Care Public Hospital, Karachi.

Ale Zehra, Tehreem Ansari, Syed Shaukat Ali Muttaqi Shah, Beenish Syed, Mehwish Rizvi, Fakhsheena Anjum, Tehrim Fatima, Farah Saeed

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Drug-related problems and their predictors in pediatric community-acquired infections: the role of pharmacist-led interventions in Pakistan.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ale ZehraDepartment of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Dow College of Pharmacy, Dow University of Health Sciences, Karachi, Sindh, Pakistan.
Tehreem AnsariDepartment of Infectious Disease, Dow University Hospital (Ojha Campus), Dow University of Health Sciences, Karachi, Sindh, Pakistan.
Syed Shaukat Ali Muttaqi ShahCollege of Pharmacy, Al-Farahidi University, Baghdad, Iraq.ORCID https://orcid.org/0009-0001-4231-0838
Beenish SyedDepartment of Infectious Disease, Dow University Hospital (Ojha Campus), Dow University of Health Sciences, Karachi, Sindh, Pakistan.
Mehwish RizviDepartment of Pharmaceutics, Faculty of Pharmaceutical Sciences, Dow College of Pharmacy, Dow University of Health Sciences, Karachi, Sindh, Pakistan.
Fakhsheena AnjumDepartment of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Dow College of Pharmacy, Dow University of Health Sciences, Karachi, Sindh, Pakistan.
Tehrim FatimaDepartment of Pharmacology, Faculty of Pharmaceutical Sciences, Dow College of Pharmacy, Dow University of Health Sciences, Karachi, Sindh, Pakistan.
Farah SaeedDepartment of Pharmacognosy, Faculty of Pharmaceutical Sciences, Dow College of Pharmacy, Dow University of Health Sciences, Karachi, Sindh, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAntimicrobial resistance (AMR) is a global threat, mainly linked to inappropriate use and prescription of antibiotics, Antimicrobial stewardship (AMS) programs have proved to promote responsible antibiotic use and decrease the burden of AMR. The aim of this study is to benchmark antibiotic prescribing patterns and evaluate stewardship practices using the World Health Organization (WHO) Point Prevalence Survey (PPS) methodology in a tertiary care public sector hospital in Karachi.

methodA cross-sectional, prospective PPS was conducted over four weeks in July 2024 at Dow University Hospital, Karachi. The data were extracted from the medical records of the patients using a validated WHO PPS tool by a trained infectious disease physician and pharmacist. All inpatients admitted before or at 8:00 a.m. on survey day, without a planned discharge were included, excluding those from emergency, acute care, day-care surgery, dialysis, and oncology units. Descriptive analysis of the data was performed using Stata version 14.

resultsOut of 224 hospitalized patients at the day of survey, 186 inpatients (adults and children across medical, surgical and critical care wards) were included in the study meeting the inclusion criteria. The study included 50.5% male and 49.5% females, having mean age of 45 (±18) years. The point prevalence of antibiotic use was 83.3% (95% CI: 77.5-88.2%). Community-acquired infections 55.5% (95% CI: 48.7-62.1%) were the most common indication of use. Most antibiotics 99.2%, (95% CI: 95.6-99.9%) were prescribed empirically, with predominant parenteral administration 89.2% (95% CI: 84.5-92.9%) and limited Intravenous-to-oral switch 2.9% (95% CI: 1.3-6.2%). Ceftriaxone (18.5%), piperacillin-tazobactam (18.1%), and meropenem (16.2%) were most frequently used antibiotics. According to WHO Access, Watch and Reserve (AWaRe) classification, 80.8% (95% CI: 75.2-85.6%) of antibiotics belonged to the 'Watch' category, 17.3% (95% CI: 12.6-23.2%) to 'Access', and 1.8% (95% CI: 0.7-4.6%) to 'Reserve'. Cultures showed no growth in 64.8% (95% CI: 55.2-73.6%) of cases. Stewardship interventions were found applicable in 55.4% (95% CI: 48.7-62.0%) of prescriptions due to overuse, dosing errors, and absence of antimicrobial guideline in the hospitals.

conclusionThis study demonstrates that antibiotic utilization exceeded global averages, highlighting the urgent need to develop institutional antimicrobial guidelines, enhance stewardship programs, and improve diagnostic stewardship to curb AMR.

Indexed as

Anti-Bacterial AgentsAntimicrobial StewardshipBenchmarkingPractice Patterns, Physicians'AdolescentAdultAgedChildCross-Sectional StudiesDrug PrescriptionsFemaleHospitals, PublicHumansMaleMiddle AgedPakistanAnti-Bacterial Agents

Identifiers

PMID41734200
PMCPMC12931792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.